Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-04-18Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
-
CLINICAL_TRIALS study record update · 2025-04-18Phase I/II Intratumoral Administration of Hu14.18-IL2, With Local Radiation, Nivolumab and Ipilimumab in Subjects With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2025-04-15LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
-
CLINICAL_TRIALS study record update · 2025-04-13A Phase Ib, Open-label, Multicenter Study of Oral LXH254-centric Combinations in Adult Patients With Advanced or Metastatic KRAS or BRAF Mutant Non-Small Cell Lung Cancer or NRAS Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2025-04-10A Dose-escalation and Expansion Phase I/IIa Study of XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation (ENHANCE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-06Immune Profiles Evolution in Patients Treated by Immunotherapy for Melanoma
-
CLINICAL_TRIALS study record update · 2025-04-06A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab With Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants With High-risk Stage II-IV Melanoma (KEYVIBE-010)
-
CLINICAL_TRIALS study record update · 2025-04-04A Phase II, Open-label, Randomized, Multi-center Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal and Acral Melanoma Who Had Not Previously Received Systemic Therapy
-
CLINICAL_TRIALS study record update · 2025-04-04Evaluating the Current Standard of Care for Patients Diagnosed With Malignant Melanoma of the Head and Neck - Access to Staging and Surgical Treatment
-
CLINICAL_TRIALS study record update · 2025-04-02A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of KY1044 as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-04-02A Multicenter, Open-label, Phase 2 Study of Intratumoral CMP-001 in Combination With Intravenous Nivolumab in Subjects With Refractory Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2025-03-30Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors: TIRACAN
-
CLINICAL_TRIALS study record update · 2025-03-28Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)
-
CLINICAL_TRIALS study record update · 2025-03-26Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Select Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-03-21Phase I Study of TTI-101, an Oral Inhibitor of Signal Transducer and Activator of Transcription (STAT) 3, in Patients With Advanced Cancers
-
CLINICAL_TRIALS study record update · 2025-03-21Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff
-
CLINICAL_TRIALS study record update · 2025-03-20A Phase 1b/2, Open-label, Dose Escalation Study of Entinostat in Combination With Pembrolizumab in Patients With Non-small Cell Lung Cancer, With Expansion Cohorts in Patients With Non-small Cell Lung Cancer, Melanoma, and Mismatch Repair-Proficient Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2025-03-18Perioperative Treatment With Tranexamic Acid in Melanoma; Prognostic and Treatment-related Impact of the Plasminogen-plasmin Pathway
-
CLINICAL_TRIALS study record update · 2025-03-14Phase 1 Dose Escalation and Dose Expansion Study of an Agonist Redirected Checkpoint Fusion Protein, SL-279252 (PD1-Fc-OX40L), in Subjects With Advanced Solid Tumors or Lymphomas
-
CLINICAL_TRIALS study record update · 2025-03-13"NEOadjuvant Plus Adjuvant Therapy With Combination or Sequence of Vemurafenib, cobImetinib, and atezolizuMab in Patients With High-risk, Surgically Resectable BRAF Mutated and Wild-type Melanoma"
-
CLINICAL_TRIALS study record update · 2025-03-13A Phase 2 Study of INCB086550 (Oral PD-L1 Inhibitor) in Participants Who Are Immune Checkpoint Inhibitor-Naïve With Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-03-12BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients in the Adjuvant Setting: a Non-interventional Observatory Study
-
CLINICAL_TRIALS study record update · 2025-03-12A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)
-
CLINICAL_TRIALS study record update · 2025-03-11In Vivo Liquid Biopsy for Early Detection of Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2025-03-10Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors